Literature DB >> 30201493

APOL1-miR-193 Axis as a Bifunctional Regulator of the Glomerular Parietal Epithelium: Maintaining Parietal Cell Phenotype versus Promoting Podocyte Differentiation.

Joseph Jessee1, Jeffrey B Kopp2.   

Abstract

This commentary highlights the article by Kumar et al that reports an essential role of APOL1 in maintaining podocyte phenotype. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30201493      PMCID: PMC6207100          DOI: 10.1016/j.ajpath.2018.08.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

Review 2.  Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.

Authors:  Jurgen Heymann; Cheryl A Winkler; Maarten Hoek; Katalin Susztak; Jeffrey B Kopp
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

3.  APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.

Authors:  Alex N Kasembeli; Raquel Duarte; Michèle Ramsay; Pulane Mosiane; Caroline Dickens; Thérèse Dix-Peek; Sophie Limou; Efe Sezgin; George W Nelson; Agnes B Fogo; Stewart Goetsch; Jeffrey B Kopp; Cheryl A Winkler; Saraladevi Naicker
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

4.  Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu.

Authors:  Abheepsa Mishra; Kamesh Ayasolla; Vinod Kumar; Xiqian Lan; Himanshu Vashistha; Rukhsana Aslam; Ali Hussain; Sheetal Chowdhary; Shadafarin Marashi Shoshtari; Nitpriya Paliwal; Waldemar Popik; Moin A Saleem; Ashwani Malhotra; Leonard G Meggs; Karl Skorecki; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-10

5.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

6.  The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions.

Authors:  Eric E Smith; Harmit S Malik
Journal:  Genome Res       Date:  2009-03-19       Impact factor: 9.043

7.  MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype.

Authors:  Leonie Kietzmann; Sebastian S O Guhr; Tobias N Meyer; Lan Ni; Marlies Sachs; Ulf Panzer; Rolf A K Stahl; Moin A Saleem; Dontscho Kerjaschki; Christoph A Gebeshuber; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

8.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

9.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Authors:  Michael S Lipkowitz; Barry I Freedman; Carl D Langefeld; Mary E Comeau; Donald W Bowden; W H Linda Kao; Brad C Astor; Erwin P Bottinger; Sudha K Iyengar; Paul E Klotman; Richard G Freedman; Weijia Zhang; Rulan S Parekh; Michael J Choi; George W Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612

10.  APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.

Authors:  Duncan B Johnstone; Vijay Shegokar; Deepak Nihalani; Yogendra Singh Rathore; Leena Mallik; Vasant Zare; H Omer Ikizler; Rajaram Powar; Lawrence B Holzman
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more
  2 in total

Review 1.  The Pathology Lesion Patterns of Podocytopathies: How and why?

Authors:  Fiammetta Ravaglia; Maria Elena Melica; Maria Lucia Angelotti; Letizia De Chiara; Paola Romagnani; Laura Lasagni
Journal:  Front Cell Dev Biol       Date:  2022-02-24

2.  Knockdown of lncRNA MALAT1 ameliorates acute kidney injury by mediating the miR-204/APOL1 pathway.

Authors:  Hai-Yuan Lu; Guo-Yi Wang; Jin-Wen Zhao; Hai-Tao Jiang
Journal:  J Clin Lab Anal       Date:  2021-07-09       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.